MET and lung carcinoma: Moreover, using inhibitors for both c-Met and PARP synergistically have anti-tumor, and antiproliferative potential via disrupting tumor growth, suppressing invasion and promoting DNA damage which in turn triggers apoptotic cell death in lung cancer [64].